| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |